Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma
Authors
Keywords
Salivary gland adenoid cystic carcinoma, Pim-1, RUNX3
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-30
DOI
10.1186/s13046-014-0114-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
- (2015) Ulrike Weirauch et al. NEOPLASIA
- A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers
- (2014) Z. Q. Ling et al. ANNALS OF ONCOLOGY
- The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro
- (2013) Riccardo Adamo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
- (2013) Jun Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest
- (2013) Guilin Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients
- (2013) Yong-hai Peng et al. PLoS One
- The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
- (2012) Q. Yang et al. BLOOD
- Expressions of osteopontin (OPN), ανβ3 and Pim-1 associated with poor prognosis in non-small cell lung cancer (NSCLC)
- (2012) Yi Jin et al. Chinese Journal of Cancer Research
- RUNX family: Regulation and diversification of roles through interacting proteins
- (2012) Linda Shyue Huey Chuang et al. INTERNATIONAL JOURNAL OF CANCER
- PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells
- (2012) Xiao-Fen Lai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
- (2012) Marjo Malinen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The PIM kinases in hematological cancers
- (2012) Yesid Alvarado et al. Expert Review of Hematology
- Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
- (2011) L. S. Chen et al. BLOOD
- Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
- (2011) Benedict Yan et al. Gastric Cancer
- Molecular biology of adenoid cystic carcinoma
- (2011) Jia Liu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- TGF-β1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma
- (2011) L. Dong et al. JOURNAL OF DENTAL RESEARCH
- Adenoid cystic carcinoma: A rare clinical entity and literature review
- (2011) Shailesh M. Gondivkar et al. ORAL ONCOLOGY
- Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
- (2010) Jongchan Kim et al. BMC CANCER
- Why target PIM1 for cancer diagnosis and treatment?
- (2010) Nancy S Magnuson et al. Future Oncology
- Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis
- (2008) Jian-Feng He et al. CANCER SCIENCE
- Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization
- (2008) Hye-Ryun Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now